Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Article | IMSEAR | ID: sea-195344

ABSTRACT

There is considerable significance for partial genetical overlap between schizophrenia and bipolar disordersbased on family and twin studies. Though the two disorders are treated differently by their diagnosticcategories, recent evidence supports that they are more closely associated. Inspite of considerable overlapin epidemiologic features, there is no specification of the risk factors. Moreover, a significant overlap in thegenes contributing to schizophrenia and bipolar disorder has been revealed by family and twin studies.Keeping all these in view, the findings in various studies from the worldwide are reviewed after a carefulresearch of articles published in Indian journal of psychiatry, Libigenesis, Scihub and Pubmed

2.
Article | IMSEAR | ID: sea-186581

ABSTRACT

Introduction: Coping responses are being targeted in psychological interventions as they have the capacity to distinctly influence the illness course. Identifying the coping strategies in patients of Bipolar Mood Disorder thus becomes essential part for treatment design, due to differential coping preferences having etiological and clinical implications. Most studies till date have focused on bipolar I disorder, the current study examines the cognitive coping profiles in both bipolar I (BD I) and bipolar II mood disorder (BD II) patients, and compared them. Aim: To examine the cognitive coping strategies in Bipolar I and Bipolar II patients and how they differ from each other. Material and methods: A total of 100 participants were segregated using MINI and divided into groups based on DSM-IV TR. Participants (62 BD I patients and 38 BD II patients) were analyzed for preferential cognitive coping strategies using the Cognitive Emotion Regulation Questionnaire. Results: BD I patients scored significantly higher on most adaptive coping subscales of CERQ as compared to BD II patients. Conclusion: BD I patients used more adaptive coping strategies as compared to BD II patients.

3.
Article in English | IMSEAR | ID: sea-159448

ABSTRACT

Aim: To compare the disability in the persons with Schizophrenia and persons with Bipolar Mood Disorder by using IDEAS from a GHPU Mental Health Treatment Users. Objectives: 1.To assess the level of disability in the area of self care, interpersonal activities, communication and understanding and in the area of work in persons with Schizophrenia and in persons with Bipolar Mood Disorder. 2. To evaluate & compare the extent of disability found in Schizophrenia and Bipolar Mood Disorder. Method: Thirty individuals with schizophrenia and thirty individuals with Bipolar Mood Disorder along with significant caregiver were assessed by administering IDEAS. The data was analyzed to prioritize the need for psychosocial interventions along with pharmacological interventions; to reduce disability during hospitalization. Individuals with co-morbid condition and illness duration less than two year were excluded. Result: Majority of persons with Schizophrenia had severe, moderate, profound disability in psychosocial role functioning where as most of the persons with Bipolar Mood Disorder had only mild to moderate disability. Conclusion: Disability was found to be more in persons with Schizophrenia compared to persons with Bipolar Mood Disorder.


Subject(s)
Bipolar Disorder/complications , Bipolar Disorder/psychology , Disability Evaluation/methods , Hospitals, General , Humans , India , Psychiatric Department, Hospital , Schizophrenia/complications , Schizophrenia/psychology
4.
ASEAN Journal of Psychiatry ; : 220-223, 2010.
Article in English | WPRIM | ID: wpr-625751

ABSTRACT

Objective: This case reports highlight atypical presentation of pediatric bipolar mood disorder. Pediatric bipolar disorder is said to be a rare condition with some distinct differences from adult bipolar disorder. Despite the ongoing controversy regarding its exact typology, pediatric bipolar mood disorder is being reported in the form of case reports and in systematic research. Pediatric bipolar disorder is difficult to diagnose because its presentation of symptoms overlaps considerably with conduct problems, and ADHD (attention deficit hyperkinetic disorder). Methods: We report two cases which met a diagnosis of pediatric mood disorder where the presentation of symptoms was unique and atypical. Results: The cases are presented so that they help to raise pertinent questions regarding phenomenology, duration, episodic nature of the illness and management of this important group of disorders. Conclusion: Pediatric bipolar disorder should be viewed with seriousness and pediatric mania should be given importance in the assessment of the typology, prognosis and management of this important group of childhood disorder.

5.
Braz. j. pharm. sci ; 45(2): 249-256, Apr.-June 2009. graf, tab
Article in English | LILACS | ID: lil-525902

ABSTRACT

The Bipolar Mood Disorder is characterized by the alternation of depressive crises with episodes of mania or euphoria, having these patients 15 to 35 times more chances of suicide, as compared with people without this disorder. The pharmacotherapy is fundamental for this disease, aiming to decrease the frequency of episodes and disease severity. In these patients, the polypharmacy has recently increased and one of the main difficulties is the adherence to treatment. The objective of this study was to contribute for the improvement of bipolar patients health conditions, developing their respective pharmacotherapeutic follow-up. Twenty eight adult bipolar patients who were participants of a specialized clinic within a tertiary hospital in Porto Alegre have been randomly selected, and the Dader Method of pharmacotherapeutic follow-up has been applied. The more common clinical comorbidities were: hypertension (50 percent), obesity (46.43 percent), and hypothyroidism (36.29 percent). The bipolar patients are more susceptible to clinical comorbidities, and many of them could be due to pharmacotherapy. Only 1.43 percent of patients presented Drug Related Problems, being all of them resolved along the study. It was also observed that 32.14 percent of evaluated patients presented low adherence to treatment, and between these patients, 55.56 percent passed to have good adherence after pharmacotherapeutic follow-up. The pharmacotherapeutic follow-up is fundamental for the improvement of patient's health. New studies, with higher number of patients and longer duration, are necessary to evaluate the percentage of patients that could be beneficiary of Pharmaceutical Care.


O Transtorno do Humor Bipolar é caracterizando pela alternância de crises depressivas com episódios de mania ou euforia, tendo estes pacientes 15-35 vezes mais chances de suicídio em comparação com pessoas sem este transtorno. A farmacoterapia é fundamental, visando diminuir a freqüência dos episódios e a gravidade da doença. Nestes pacientes, a polifarmácia tem aumentado ultimamente e uma das maiores dificuldades é a adesão ao tratamento. O objetivo do estudo foi contribuir para a melhoria das condições de saúde de pacientes bipolares, realizando o acompanhamento farmacoterapêutico dos mesmos. Foram selecionados aleatoriamente 28 pacientes bipolares adultos, participantes de um ambulatório especializado de um hospital terciário em Porto Alegre e aplicado o Método Dáder de acompanhamento farmacoterapêutico. As co-morbidades clínicas mais comuns foram: hipertensão (50 por cento), obesidade (46,43 por cento) e hipotiroidismo (39,29 por cento). Os pacientes bipolares são mais suscetíveis a co-morbidades clínicas e muitas destas podem ser devidas a farmacoterapia. Apenas 1,43 por cento dos pacientes apresentavam Problemas Relacionados a Medicamentos, sendo todos solucionados no decorrer do estudo. Também se observou que 32,14 por cento dos pacientes avaliados apresentavam baixa adesão ao tratamento e entre estes, 55,56 por cento passaram a ter boa adesão após o acompanhamento farmacoterapêutico. É fundamental para a melhoria da saúde do paciente o acompanhamento farmacoterapêutico. Novos estudos, com maior número de pacientes e maior duração, são necessários para avaliar o percentual de pacientes que poderão ser beneficiados pela Atenção Farmacêutica.


Subject(s)
Humans , Male , Female , Adult , Pharmaceutical Services/organization & administration , Pilot Projects , Bipolar Disorder/drug therapy , Continuity of Patient Care , Health Status
SELECTION OF CITATIONS
SEARCH DETAIL